CD36 IS REQUIRED FOR PHAGOCYTOSIS OF APOPTOTIC CELLS BY HUMAN MACROPHAGES THAT USE EITHER A PHOSPHATIDYLSERINE RECEPTOR OR THE VITRONECTIN RECEPTOR (ALPHA(V)BETA(3))
Va. Fadok et al., CD36 IS REQUIRED FOR PHAGOCYTOSIS OF APOPTOTIC CELLS BY HUMAN MACROPHAGES THAT USE EITHER A PHOSPHATIDYLSERINE RECEPTOR OR THE VITRONECTIN RECEPTOR (ALPHA(V)BETA(3)), The Journal of immunology (1950), 161(11), 1998, pp. 6250-6257
In vivo, apoptotic cells are efficiently removed by professional or no
nprofessional phagocytes, a process thought to be essential for tissue
remodeling and resolution of inflammation. Macrophages recognize apop
totic cells by several mechanisms, including recognition of exposed ph
osphatidylserine (PS); however, PS recognition on apoptotic cells has
not been identified as a feature of human macrophages, The purpose of
this study was to determine whether human monocyte-derived macrophages
could be stimulated to recognize PS, defined as inhibition of phagocy
tosis by PS-containing liposomes. We also assessed the potential roles
for scavenger receptors, CD14, and lectins. Uptake of apoptotic neutr
ophils into unstimulated macrophages was blocked about 50% by Arg-Gly-
Asp-Ser and anti-alpha(v), and up to 20% by oxidized low density lipop
rotein and N-acetylglucosamine, implying a major role for integrin and
minor roles for scavenger and lectin receptors, Uptake into macrophag
es stimulated with beta-1,3-glucan was blocked 50% by PS liposomes and
40% by oxidized low density lipoprotein, suggesting that the macropha
ges had switched from using integrin to recognition of PS, MEM-18 and
61D3 (anti-CD14 mAbs) were poor inhibitors of apoptotic neutrophil upt
ake, but good inhibitors of apoptotic lymphocyte uptake. The switch to
PS recognition was accompanied by down-regulation of alpha(v)beta(3)
expression and function. Anti-CD36 blocked uptake into unstimulated or
stimulated macrophages,suggesting CD36 involvement not only with the
alpha(v)beta(3) integrin mechanism (as previously reported) but also w
ith PS recognition. A maximum of 70% inhibition was achieved by combin
ing anti-CD36 with either anti-a(v) or PS liposomes.